| RS2067019858 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067020259 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067020544 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067021249 |
NF1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2067030499 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067030828 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067031065 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067031123 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067031470 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067032198 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067032355 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067037065 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067037428 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2067037681 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067037965 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067038047 |
NF1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Neurofibromatosis |
| RS2067038120 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067038509 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067039276 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067039387 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067039946 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis |
| RS2067060145 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2067064355 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067064699 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067064931 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067065066 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2067065463 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067065647 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2067065846 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067065917 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067066435 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067066922 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067066952 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067067405 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067069052 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067070365 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2067071059 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067071714 |
OPN1LW
|
Health Risk |
Pathogenic |
Cone monochromatism, Cone monochromatism |
| RS2067071786 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067072110 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067072148 |
OPN1LW
|
Health Risk |
Pathogenic |
— |
| RS2067072694 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067073056 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067073241 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067073865 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067074098 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067074423 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067074457 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067079746 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2067082634 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067082667 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067083148 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2067083151 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067083389 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2067083472 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067083695 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067084312 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067084444 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067084803 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067085335 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2067087661 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2067089729 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067090473 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067090561 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067091045 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067091492 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2067091515 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067091604 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067091646 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067091885 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067091912 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067092112 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067092561 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067099763 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability Najm type, Intellectual disability |
| RS2067100386 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Syndromic X-linked intellectual disability Najm type |
| RS2067101256 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2067101855 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067102269 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2067102964 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067108651 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, COL4A5-related disorder |
| RS2067109223 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2067109423 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2067110004 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2067110688 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2067111489 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 3, RPGR-related retinopathy |
| RS2067114709 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 3 |
| RS2067115815 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS2067116490 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067117239 |
RPGR
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2067117666 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2067118339 |
RPGR
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 3, Primary ciliary dyskinesia |
| RS2067122084 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067122183 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2067122345 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067122558 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS2067122696 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067122982 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067123355 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067123493 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2067123721 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |